Topic
stem cell research
198 published works
Food Safety News
Scientists using stem cell technology in pursuit of E. coli infection treatments
By Coral Beach
A researcher in search of treatments for potentially fatal E. coli infections says the impossible is now plausible because of stem cell technology and organoids of intestinal tissues. Antibiotics are…
Focus on Regulation
FTC takes on deceptive stem cell therapy claims for blindness cure and autism treatment
By David Horowitz, Susan Lee, Lowell Zeta
On October 18, the Federal Trade Commission (FTC) announced it settled charges against California-based Regenerative Medical Group, Telehealth Medical Group, and the founder of both companies, Dr. Bryn Jarald Henderson,…
All About Advertising Law
FTC Stems Doc’s Stem Cell Claims
By Leonard L. Gordon, Matthew S. Renick
The Federal Trade Commission ("FTC") recently settled a case against a physician and his two clinics over allegedly deceptive and unsubstantiated claims relating to their "amniotic stem cell therapy." The…
Hunton Retail Law Resource
Consumer Protection in Retail: Weekly Roundup
By Phyllis H. Marcus, Carter C. Simpson
This past week, several consumer actions made headlines that affect the retail industry.
New England IP Blog
Inventorship Claim in Disease Treatment Patent Dispute Survives Motion to Dismiss
Determining who qualifies as an inventor on a patent application requires careful attention to the facts surrounding each person’s contribution to conception of the invention, as embodied in the patent…
Focus on Regulation
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
By Mike Druckman, Randy Prebula, David Horowitz, Robert Church, Lowell Zeta, Suzanne Levy Friedman, Jane Kalinina
On Wednesday, FDA announced that it filed two complaints in federal court seeking injunctions to stop marketing efforts of unapproved stem cell treatments by US Stem Cell Clinic of Sunrise,…
Focus on Regulation
The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns
By Robert Church, Mike Druckman, David Horowitz, Jim Johnson, Lowell Zeta
Yesterday, FDA published a January 3, 2018 Warning Letter issued to American CryoStem for marketing Atcell—an adipose tissue derived stem cell product—without FDA approval and for several drug current Good…
Focus on Regulation
Continuing Coverage of FDA’s Crackdown on Stem Cell Clinics: Florida Clinic Cited for Unapproved Marketing and Inadequate Sterility Assurance
By David Horowitz, Lowell Zeta, Jim Johnson, Mike Druckman, Robert Church
On the same day that FDA’s Commissioner, Dr. Scott Gottlieb, announced new policy initiatives regarding stem cell therapies and regenerative medicine, FDA announced stepped up enforcement in this area and…
The Right Coast
Could Sea Creature Slime and Stem Cells Put an End to Scars? | Fast Forward | OZY
Dr. Maral Skelsey recently examined a 10-year-old girl who was extremely self-conscious and in pain from a scalding accident that had left a discolored burn on her leg. If the…
Focus on Regulation
FDA Seizes Stem Cell Therapy—A First of Many?
By Jim Johnson, Mike Druckman, Robert Church, David Horowitz
On August 25, 2017, U.S. Marshals Service, at the request of FDA, seized five vials of ACAM20000—a smallpox vaccine containing live vaccinia virus (cow pox), which is reserved for people…